-
公开(公告)号:AR029741A1
公开(公告)日:2003-07-16
申请号:ARP000100036
申请日:2000-01-06
Applicant: BASF AG
Inventor: STEINER GERD , SCHELLHAAS KURT , LUBISCH WILFRIED , HOLZENKAMP UTA , STARCK DOROTHEA , SZABO LASZLO , EMLING FRANZ , GARCIA-LADONA FRANCISCO , HOFMANN HANS-PETER , UNGER LILIANE
IPC: C07D275/06 , A61K31/4439 , A61K31/454 , A61K31/496 , A61K31/502 , A61K31/517 , A61K31/519 , A61K31/522 , A61K31/55 , A61K31/551 , A61P9/10 , A61P25/28 , C07D401/12 , C07D417/12 , C07D471/04 , A61K31/428 , A61K31/469
Abstract: Uso de compuestos heterocíclicos N-sustituidos de formula (1) donde: A representa alquileno C1-10 ramificado o no ramificado, o alquileno C2-10 de cadena recta o ramificada, que por lo menos comprende un grupo Z que está elegido entre O, S, NR8, ciclopropilo, CO2, CHOH, un doble o triple enlace; B representa 4-piperidina, 4-tetrahidro-1,2,3,6-piridina, 4-piperazina o los correspondientes compuestos anulares agrandados por el agregado de un grupo metileno, donde el enlace con A se produce a través de un átomo de N de B; y Ar representa fenilo que, dado el caso, está sustituido por alquilo C1-6 ramificado o no ramificado, O-alquilo C1-6 ramificado o no ramificado, OH, F, Cl, Br, I, trifluorometilo, NR22, CO2R2, ciano o fenilo, tetralina, indano, grupos aromáticos de condensacion superior, como naftaleno que, dado el caso, está sustituido por alquilo C1-4 u O-alquilo C1-4, antraceno o heterociclos aromáticos de 5 o 6 eslabones, de 1 a 2 heteroátomos que, independientemente entre sí, están elegidos entre O y N, que además pueden estar anillados todavía con otros restos aromáticos; la parte cíclica que contiene al Nitrogeno está representada por las estructuras (2) o (3); uno de los dos restos X, Y representa CH2 y el otro NR9; y los sustituyentes R1, R2, R3, R4, R5, R6, R7, R8 y R9 son como se definen en la memoria descriptiva; como también sus sales con ácidos farmacologicamente tolerables, para la profilaxis y la terapia de la isquemia cerebral y la apoplejía.
-
公开(公告)号:AT239015T
公开(公告)日:2003-05-15
申请号:AT99942792
申请日:1999-07-20
Applicant: BASF AG
Inventor: STEINER GERD , HOEGER THOMAS , UNGER LILIANE , TESCHENDORF HANS-JUERGEN , JUCHELKA FRIEDER
IPC: A61K31/4184 , A61P25/20 , A61P25/24 , A61P25/30 , C07D403/06
Abstract: The invention relates to compounds of formula (1), wherein R , R and R have the meaning cited in the description. The novel substances are suitable for use in disease control.
-
153.
公开(公告)号:HRP20010472A2
公开(公告)日:2003-04-30
申请号:HRP20010472
申请日:2001-06-21
Applicant: BASF AG
Inventor: MUNSCHAUER RAINER , GROSS GERHARD , TRAUT MARTIN , UNGER LILIANE , TESCHENDORF HANS-JUERGEN
IPC: C07D403/06 , A61K31/403 , A61K31/4045 , A61K31/407 , A61K31/4184 , A61K31/424 , A61K31/427 , A61K31/4709 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/517 , A61K31/519 , A61K31/542 , A61P25/00 , A61P25/28 , A61P25/30 , A61P25/36 , C07D209/52 , C07D407/12 , C07D409/12 , C07D417/06 , C07D471/04 , C07D498/04 , C07D513/04 , A61K31/416 , A61K31/428 , A61K31/538
Abstract: The invention relates to the use of N-substituted 3-azabicycloalkane derivatives of formula (I), wherein B, R , R and n have the meanings given in the description, for combating diseases of addiction and other diseases of the central nervous system.
-
公开(公告)号:PL350246A1
公开(公告)日:2002-12-02
申请号:PL35024600
申请日:2000-01-12
Applicant: BASF AG
Inventor: STARCK DOROTHEA , TREIBER HANS-JOERG , UNGER LILIANE , NEUMANN-SCHULTZ BARBARA , BLUMBACH KAI , SCHOEBEL DIETMAR
IPC: A61K31/41 , A61K31/4196 , A61K31/422 , A61K31/4245 , C07D249/14 , A61K31/427 , A61K31/436 , A61K31/4439 , A61K31/4725 , A61K31/473 , A61K31/496 , A61K31/497 , A61K31/5377 , A61K31/55 , A61P3/04 , A61P9/00 , A61P9/10 , A61P13/12 , A61P15/10 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P25/30 , A61P25/32 , A61P25/34 , A61P25/36 , A61P43/00 , C07D249/12 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/12 , C07D403/14 , C07D405/06 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/14 , C07D417/04 , C07D417/12 , C07D417/14 , C07D491/04 , C07D491/052
Abstract: Triazole compounds of the following formulawhere R1, R2, A and B have the meanings given in the description are described. The compounds according to the invention possess a high affinity for the dopamine D3 receptor and can therefore be used for treating diseases which respond to the influence of dopamine D3 ligands.
-
公开(公告)号:ZA200106585B
公开(公告)日:2002-08-12
申请号:ZA200106585
申请日:2001-08-10
Applicant: BASF AG
Inventor: STARCK DOROTHEA , TREIBER HANS-JOERG , UNGER LILIANE , NEUMANN-SCHULTZ BARBARA , BLUMBACH KAI , SCHOEBEL DIETMAR
IPC: A61K31/41 , A61K31/4196 , A61K31/422 , C07D249/14 , A61K31/4245 , A61K31/427 , A61K31/436 , A61K31/4439 , A61K31/4725 , A61K31/473 , A61K31/496 , A61K31/497 , A61K31/5377 , A61K31/55 , A61P3/04 , A61P9/00 , A61P9/10 , A61P13/12 , A61P15/10 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P25/30 , A61P25/32 , A61P25/34 , A61P25/36 , A61P43/00 , C07D249/12 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/12 , C07D403/14 , C07D405/06 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/14 , C07D417/04 , C07D417/12 , C07D417/14 , C07D491/04 , C07D491/052 , C07D , A61K , A61P
Abstract: Triazole compounds of the following formulawhere R1, R2, A and B have the meanings given in the description are described. The compounds according to the invention possess a high affinity for the dopamine D3 receptor and can therefore be used for treating diseases which respond to the influence of dopamine D3 ligands.
-
公开(公告)号:SK8682001A3
公开(公告)日:2002-08-06
申请号:SK8682001
申请日:1999-12-09
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KETTSCHAU GEORG , RIECHERS HARTMUT , BAUMANN ERNST , HERGENRODER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: C07D251/24 , A61K31/505 , A61K31/506 , A61K31/53 , A61P9/04 , A61P9/10 , A61P9/12 , A61P13/08 , A61P13/12 , A61P15/10 , A61P35/00 , A61P43/00 , C07C229/34 , C07C233/87 , C07C235/52 , C07D239/34 , C07D251/22 , C07D401/12 , C07D491/048 , C07D239/60
Abstract: The invention relates to carboxylic acid derivatives of formula (I), in which the substituents have the following meanings: R is tetrazol or a group (a); W and Z, can be identical or different and are nitrogen or methine, provided that if W and Z are methine, then Q is nitrogen; X is nitrogen or CR ; Y is nitrogen or CR ; Q is nitrogen or CR , provided that if Q is nitrogen then X is CR and Y is CR ; R and R are identical or different and are possibly substituted phenyl or naphthyl or phenyl or naphthyl which are linked in an ortho position via a direct bond, a methlyene, ethylene or ethenylene group, an oxygen or sulfur atom or a SO2-, NH- or N-alkyl group or possibly substituted C5-C6-cycloalkyl; R is a rest (b) or (c); and R is hydrogen, C1-C4-alkyl. The invention further relates to their preparation and their use as endothelin receptor antagonists. The invention also relates to compounds of formula (II) and a structural fragment of formula (d) in which the rests R , R , R , R and R have the meanings given in claim no. 1 and to their use as structural elements in an endothelin receptor antagonist.
-
公开(公告)号:BG63632B1
公开(公告)日:2002-07-31
申请号:BG10122197
申请日:1997-02-12
Applicant: BASF AG
Inventor: STEINER GERD , MUNSCHAUER RAINER , HOEGER THOMAS , UNGER LILIANE , TESCHENDORF HANS-JUERGEN
IPC: C07D409/12 , A61K31/40 , A61K31/403 , A61P25/18 , A61P43/00 , C07D209/44 , C07D209/52 , C07D209/90 , C07D209/92 , C07D403/06
Abstract: The invention relates to new compounds having the formula where A, R1 and n have the meanings given in the description. 4 claims
-
公开(公告)号:DE59510244D1
公开(公告)日:2002-07-18
申请号:DE59510244
申请日:1995-07-14
Applicant: BASF AG
Inventor: HELLENDAHL BEATE , LANSKY ANNEGRET , MUNSCHAUER RAINER , BIALOJAN SIEGFRIED , UNGER LILIANE , TESCHENDORF HANS-JUERGEN , WICKE KARSTEN , DRESCHER KARLA
IPC: C07D239/26 , A61K31/505 , A61K31/506 , A61P25/16 , A61P25/24 , A61P25/26 , C07D239/38 , C07D239/46 , C07D239/56 , C07D239/60 , C07D401/00 , C07D401/12
Abstract: The present invention relates to the use of pyrimidine compounds of the following formula:wherein R1, R2, R3, A, B and Ar have the meanings indicated in the description. The compounds according to the invention have a high affinity for the dopamine D3 receptor and can therefore be used to treat disorders which respond to dopamine D3 ligands.
-
159.
公开(公告)号:PL183526B1
公开(公告)日:2002-06-28
申请号:PL31846095
申请日:1995-07-21
Applicant: BASF AG
Inventor: STEINER GERD , MUNSCHAUER RAINER , HOEGER THOMAS , UNGER LILIANE , TESCHENDORF HANS-JUERGEN
IPC: C07D401/06 , A61K31/40 , A61K31/415 , A61K31/47 , A61K31/505 , A61P25/18 , A61P43/00 , C07D403/06 , C07D471/04 , C07D513/04
Abstract: PCT No. PCT/EP95/02893 Sec. 371 Date Sep. 18, 1997 Sec. 102(e) Date Sep. 18, 1997 PCT Filed Jul. 21, 1995 PCT Pub. No. WO96/04272 PCT Pub. Date Feb. 15, 1996N-substitued 3-azabicyclo[3.2.0]heptane derivatives of formula (I) in which R1, R2, A, X, Y and Z have the meanings given in the description, their method of preparation and their use as pharmacological agents.
-
公开(公告)号:NO312674B1
公开(公告)日:2002-06-17
申请号:NO991079
申请日:1999-03-04
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KLING ANDREAS , KLINGE DAGMAR , RIECHERS HARTMUT , HERGENROEDER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: A61K31/505 , A61K31/506 , A61K31/519 , A61P9/04 , A61P9/08 , A61P9/12 , A61P43/00 , C07C59/66 , C07C69/734 , C07D239/34 , C07D239/52 , C07D239/60 , C07D239/70 , C07D491/04 , C07D491/048 , C07D237/34
Abstract: The invention relates to carboxylic acid derivatives of the formula Iwhere the radicals have the meanings stated in the description, and to their use as drugs.
-
-
-
-
-
-
-
-
-